141 related articles for article (PubMed ID: 9372243)
21. c-myb and growth control.
Calabretta B; Nicolaides NC
Crit Rev Eukaryot Gene Expr; 1992; 2(3):225-35. PubMed ID: 1511186
[TBL] [Abstract][Full Text] [Related]
22. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
[TBL] [Abstract][Full Text] [Related]
23. Tumour suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism.
Galy B; Créancier L; Zanibellato C; Prats AC; Prats H
Oncogene; 2001 Mar; 20(14):1669-77. PubMed ID: 11313915
[TBL] [Abstract][Full Text] [Related]
24. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
[TBL] [Abstract][Full Text] [Related]
25. Myb binding proteins: regulators and cohorts in transformation.
Ness SA
Oncogene; 1999 May; 18(19):3039-46. PubMed ID: 10378699
[TBL] [Abstract][Full Text] [Related]
26. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta.
Kagan BL; Henke RT; Cabal-Manzano R; Stoica GE; Nguyen Q; Wellstein A; Riegel AT
Cancer Res; 2003 Apr; 63(7):1696-705. PubMed ID: 12670924
[TBL] [Abstract][Full Text] [Related]
27. Basic fibroblast growth factor-induced decrease in type I collagen gene transcription is mediated by B-myb.
Kypreos KE; Nugent MA; Sonenshein GE
Cell Growth Differ; 1998 Sep; 9(9):723-30. PubMed ID: 9751116
[TBL] [Abstract][Full Text] [Related]
28. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
29. The human neuroendocrine thyrotropin-releasing hormone receptor promoter is activated by the haematopoietic transcription factor c-Myb.
Matre V; Høvring PI; Fjeldheim AK; Helgeland L; Orvain C; Andersson KB; Gautvik KM; Gabrielsen OS
Biochem J; 2003 Jun; 372(Pt 3):851-9. PubMed ID: 12628004
[TBL] [Abstract][Full Text] [Related]
30. Linking Myb to the cell cycle: cyclin-dependent phosphorylation and regulation of A-Myb activity.
Ziebold U; Klempnauer KH
Oncogene; 1997 Aug; 15(9):1011-9. PubMed ID: 9285555
[TBL] [Abstract][Full Text] [Related]
31. Two c-myb proteins differing by their aminotermini exhibit different transcriptional transactivation activities (yeast/reporter-effector system).
Punyammalee B; Crabeel M; de Lannoy C; Perbal B; Glansdorff N
Oncogene; 1991 Jan; 6(1):11-9. PubMed ID: 1992438
[TBL] [Abstract][Full Text] [Related]
32. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells.
Zakut R; Perlis R; Eliyahu S; Yarden Y; Givol D; Lyman SD; Halaban R
Oncogene; 1993 Aug; 8(8):2221-9. PubMed ID: 7687762
[TBL] [Abstract][Full Text] [Related]
33. Myb binding sites within the N-ras promoter repress transcription.
Ganter B; Lipsick JS
Oncogene; 1997 Jul; 15(2):193-202. PubMed ID: 9244354
[TBL] [Abstract][Full Text] [Related]
34. Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines.
Thompson MA; Flegg R; Westin EH; Ramsay RG
Oncogene; 1997 Apr; 14(14):1715-23. PubMed ID: 9135073
[TBL] [Abstract][Full Text] [Related]
35. Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins.
Tantravahi R; Dudek H; Patel G; Reddy EP
Oncogene; 1996 Sep; 13(6):1187-96. PubMed ID: 8808693
[TBL] [Abstract][Full Text] [Related]
36. Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation.
Lüscher B; Christenson E; Litchfield DW; Krebs EG; Eisenman RN
Nature; 1990 Apr; 344(6266):517-22. PubMed ID: 2157164
[TBL] [Abstract][Full Text] [Related]
37. Methylation-sensitive DNA binding by v-myb and c-myb proteins.
Klempnauer KH
Oncogene; 1993 Jan; 8(1):111-5. PubMed ID: 8423989
[TBL] [Abstract][Full Text] [Related]
38. The proto-oncogene FGF-3 is constitutively expressed in tumorigenic, but not in non-tumorigenic, clones of a human colon carcinoma cell line.
Galdemard C; Brison O; Lavialle C
Oncogene; 1995 Jun; 10(12):2331-42. PubMed ID: 7784081
[TBL] [Abstract][Full Text] [Related]
39. Murine myeloid leukemias with aberrant myb loci show heterogeneous expression of novel myb proteins.
Dudek H; Reddy EP
Oncogene; 1989 Dec; 4(12):1489-95. PubMed ID: 2480562
[TBL] [Abstract][Full Text] [Related]
40. V-myb oncogene and c-myb proto-oncogene expression in avian cells: morphological changes of the cells and topographic localization of myb proteins.
Korb J; Stokrová J; Karafiát V; Dvoráková M; Cermáková V
Acta Virol; 1996 Apr; 40(2):81-6. PubMed ID: 8886116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
